Latest News & Updates
Breaking News
11 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
FDA's DMF Prior Assessment Process Opens Early Review Window for API Suppliers
FDA's GDUFA III prior assessment process lets Type II API DMF holders request review six months before ANDA submission to reduce approval delays.
Pharma Now Editorial Team
Dupixent Clears FDA for CSU in Children as Young as Two
FDA approves Dupixent for CSU in children aged 2-11, using efficacy extrapolation and PK bridging -- a regulatory model with broad pediatric biologic implications.
Pharma Now Editorial Team
Inventiva Builds Commercial Infrastructure Ahead of MASH Phase 3 Readout
Inventiva appoints CFO, CLO, and CPO ahead of NATiV3 Phase 3 lanifibranor data expected Q4 2026.
Pharma Now Editorial Team
Fixed-Dose Triple Combination Cuts Recurrent Stroke Risk by 39%
TRIDENT trial data show GMRx2 cut recurrent stroke risk by 39% in ICH survivors over three years, published in NEJM.
Pharma Now Editorial Team
